How much funding has MedGenome raised?

MedGenome has raised $161.5M in total funding, most recently a Series D round.

Who are MedGenome's investors?

MedGenome's investors include Novo Holdings A/S, Sequoia Capital, Emerge Ventures, Maj Invest, Sofina, Zodius Capital.

Where is MedGenome headquartered?

MedGenome is headquartered in Bangalore, India.

What industry is MedGenome in?

MedGenome operates in Biotech, Healthcare.

How many employees does MedGenome have?

MedGenome has 201-500 employees.

MedGenome

Decoding genetic information to improve global health.

Bangalore, India · Founded 2013 · $161.5M raised

Biotech

Healthcare

Headquarters: Bangalore
Employees: 201–500
Founded: 2013
Business Model: B2B

Website: medgenome.com
Total Funding: $161.5M
Last Round: $50.0M Series DJul 2025
Rounds: 5

About

MedGenome is a global leader in genomics-based diagnostics and research services, offering over 1,300 genetic tests spanning oncology, rare diseases, prenatal diagnostics, neurology, and infectious diseases. Founded in 2013 and headquartered in Bangalore, India, MedGenome operates across three core business lines: genomic diagnostics for clinical use, genomic research services for pharmaceutical and biotech partners, and drug discovery solutions powered by real-world genomic data. The company provides DNA sequencing, bioinformatics analysis, and multiomics services to healthcare providers, research institutions, and biopharma companies globally. Its US arm was rebranded as Signios Biosciences in 2025, offering sequencing and multiomics services from Foster City, California.

Summary

MedGenome is a Biotech company based in Bangalore, India, founded in 2013. It has raised $161.5M in total across 5 rounds, most recently a $50.0M Series D round in Jul 2025. Investors include Novo Holdings A/S, Sequoia Capital and Emerge Ventures.

LinkedIn X (Twitter)